|
 |
Environment > Hypersensitivity Diseases
The following information is about Hypersensitivity Diseases.
Hypersensitivity Diseases Defined
Diseases characterized by allergic responses to pollutants; diseases most clearly associated with indoor air quality are asthma, rhinitis, and pneumonic hypersensitivity.
This definition is in context to Environment. See more contextual defintions for Hypersensitivity Diseases.
Elan And Biogen Idec Initiate First Clinical Trial Of TYSABRI(R) In Oncology - First Multiple Myeloma Patient Treated
Published September 6, 2008, 8:14 am, Medical News Today
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced the initiation of the first clinical trial of TYSABRI® (natalizumab) in oncology. The first dose of TYSABRI was administered yesterday in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential anti-tumor activity of TYSABRI in patients with relapsed or refractory multiple myeloma.
New Zealand HIV Patients Given Hope
Published September 4, 2008, 5:50 pm, Scoop.co.nz
New Zealand HIV patients who were facing a bleak future, will now have a new treatment option thanks to ISENTRESSTM (raltegravir) being approved for use in New Zealand yesterday.
Webcast Presentation Of Results From Phase 2 Study Of ARCALYST(R) (Rilonacept) In Gout Patients Initiating ...
Published September 4, 2008, 5:12 am, Medical News Today
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that Dr. Leonard S. Schleifer, President and Chief Executive Officer of Regeneron, and other members of senior management will host a webcast conference call commencing at 8:30 a.m. Eastern Time on Wednesday, September 3, 2008. Dr.
ZymoGenetics Earns Milestone Payment for RECOTHROM(R) European Filing
Published September 2, 2008, 3:00 am, Business Wire via Yahoo! Finance
SEATTLE----ZymoGenetics, Inc. announced today that it will receive a $5 million milestone payment from Bayer HealthCare, which was triggered by the submission of the Marketing Authorization Application to the European Medicines Agency for approval to market RECOTHROM® Thrombin, topical .
Are you looking for additional Environment > Hypersensitivity Diseases news? Try our new "Hypersensitivity Diseases News Focus" area.
Social bookmarks are not available at the moment.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Hypersensitivity Diseases. If you would like to find related tags we recommend Tag Patterns > Hypersensitivity Diseases
Off-site Hypersensitivity Diseases Research Links
If you still need additional information on Hypersensitivity Diseases then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Hypersensitivity Diseases
- Alexa > Hypersensitivity Diseases
- Anti-Aging Revolution > Hypersensitivity Diseases
- DMOZ > Hypersensitivity Diseases
- Feeds Filtered > Hypersensitivity Diseases
- Google > Hypersensitivity Diseases
- News Meme > Hypersensitivity Diseases
- Nuah: News > Hypersensitivity Diseases
- The Feed Directory > Hypersensitivity Diseases
- OBP > Hypersensitivity Diseases
- Open Tag Directory > Hypersensitivity Diseases
- Podzy > Hypersensitivity Diseases
- Yahoo > Hypersensitivity Diseases
Environment Topics
Everything you need to know about Environment
Environment
If you know the Environment Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Environment.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.